Special Recognition Award
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Overview
Program Description: The Special Recognition Award honors distinguished scientists who have made exceptional contributions to cancer research through translational work or achievements in specialized categories that transcend traditional basic and clinical research boundaries. This prestigious award is presented selectively, only when recommended by the Scientific Advisory Board, ensuring that it recognizes truly extraordinary contributions to the field.
Award Status
- Selective: Awarded only when recommended by the Scientific Advisory Board
- Frequency: Not awarded every year; contingent on exceptional recommendations
Past Recipients
- Claudio Basilico, MD (2022)
- Gabriella Pravettoni, PhD (2024)
- Alberto Bardelli, PhD (2025)
What American-Italian Cancer Foundation actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 7
- Total given
- $784K
- Median grant
- $60K
- Range
- $42K–$240K
- By dollars: New York 64%, Massachusetts 23%, Connecticut 8%. Top recipient cities: New York, NY; Boston, MA; New Haven, CT.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
Memorial Sloan Kettering Cancer Center · New York, NY
Cancer research
$240K
Weill Medical College of Cornell University · New York, NY
Cancer research
$202K
Dana-Farber Cancer Institute · Boston, MA
Cancer research
$120K
NYU Grossman School of Medicine · New York, NY
Cancer research
$60K
Yale School of Medicine · New Haven, CT
Cancer research
$60K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Amount
$50K – $600K
Deadline
October 19, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
November 17, 2026
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $499,999
Deadline
January 7, 2027
Ready to apply for Special Recognition Award?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Special Recognition Award. Now let's win it.